Etisulergine

Etisulergine
Clinical data
Other names	CQ-32084; CQ 32-084; N,N-Diethyl-N'-(6-methylergolin-8α-yl)sulfamide
Drug class	Dopamine agonist; Prolactin inhibitor; Antiparkinsonian agent
Identifiers
	IUPAC name (6aR,9S,10aR)-9-(diethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline;
CAS Number	64795-23-9;
PubChem CID	68847;
ChemSpider	62080;
UNII	28N73Q6O7Y;
ChEMBL	ChEMBL38992;
CompTox Dashboard (EPA)	DTXSID101024323 ;
Chemical and physical data
Formula	C19H28N4O2S
Molar mass	376.52 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C;
	InChI InChI=1S/C19H28N4O2S/c1-4-23(5-2)26(24,25)21-14-10-16-15-7-6-8-17-19(15)13(11-20-17)9-18(16)22(3)12-14/h6-8,11,14,16,18,20-21H,4-5,9-10,12H2,1-3H3/t14-,16+,18+/m0/s1; Key:YHEIHLVIKSTGJE-YXJHDRRASA-N;

Etisulergine (INNTooltip International Nonproprietary Name; developmental code name CQ-32084 or CQ 32-084) is a drug of the ergoline family described as a dopamine agonist, prolactin inhibitor, and antiparkinsonian agent which was never marketed.^[1]^[2]^[3]^[4]^[5]^[6] It is closely related in chemical structure to lisuride and is also similar in structure to lysergic acid diethylamide (LSD).^[1]^[2] Etisulergine was first described in the literature by at least 1977.^[1]^[5]